Rajendran, Luckshi
Choi, Woo Jin
Sapisochin, Gonzalo
Article History
Received: 30 May 2023
Accepted: 30 May 2023
First Online: 13 June 2023
Disclosure
: Gonzalo Sapisochin discloses consultancy for Astra-Zeneca, Roche, Novartis, and Integra; has received financial compensation for talks for Roche, Astra-Zeneca, Chiesi, Evidera and Integra; and has received a grant from Roche. Luckshi Rajendran and Woo Jin Choi have no conflicts of interest to declare.